Prolia
| Prolia | |
|---|---|
| Term | Prolia |
| Short definition | Prolia - (pronounced) (PROH-lee-uh) drug that contains the active ingredient denosumab and is used to treat certain bone problems. Prolia is used to increase bone mass in certain patients with breast or prostate cancer who are at high risk of fractures. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Prolia - (pronounced) (PROH-lee-uh) drug that contains the active ingredient denosumab and is used to treat certain bone problems. Prolia is used to increase bone mass in certain patients with breast or prostate cancer who are at high risk of fractures. It is also used to treat osteoporosis in certain patients who are at high risk of breaking bones. Prolia attaches to a protein called RANKL, which prevents RANKL from attaching to another protein called RANK on the surface of certain bone cells. This can help prevent bone loss. Prolia is a type of monoclonal antibody
External links
- Medical encyclopedia article on Prolia
- Wikipedia's article - Prolia
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski